- Report
- January 2024
- 258 Pages
Global
€4508EUR$4,995USD£3,916GBP
- Report
- January 2024
- 120 Pages
Global
€4508EUR$4,995USD£3,916GBP
- Report
- January 2025
- 145 Pages
Global
From €2674EUR$2,963USD£2,323GBP
€3565EUR$3,950USD£3,097GBP
- Report
- January 2025
- 144 Pages
Global
From €2674EUR$2,963USD£2,323GBP
€3565EUR$3,950USD£3,097GBP
- Report
- December 2024
- 145 Pages
Global
From €2674EUR$2,963USD£2,323GBP
€3565EUR$3,950USD£3,097GBP
- Report
- May 2024
- 124 Pages
Global
From €2674EUR$2,963USD£2,323GBP
€3565EUR$3,950USD£3,097GBP
- Report
- January 2024
- 143 Pages
Global
From €2877EUR$3,188USD£2,499GBP
€3835EUR$4,250USD£3,332GBP
- Report
- June 2023
- 113 Pages
Global
From €3012EUR$3,338USD£2,617GBP
€4016EUR$4,450USD£3,489GBP
- Report
- December 2022
- 142 Pages
Global
From €3012EUR$3,338USD£2,617GBP
€4016EUR$4,450USD£3,489GBP
- Report
- August 2022
- 140 Pages
Global
From €2877EUR$3,188USD£2,499GBP
€3835EUR$4,250USD£3,332GBP
- Report
- March 2026
United Kingdom
From €3601EUR$3,990USD£3,128GBP
- Report
- December 2024
- 150 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- July 2024
- 153 Pages
Global
From €3260EUR$3,613USD£2,832GBP
€3835EUR$4,250USD£3,332GBP
- Report
- December 2023
- 241 Pages
Global
€4508EUR$4,995USD£3,916GBP
- Report
- October 2024
- 92 Pages
Europe
From €3113EUR$3,450USD£2,705GBP
- Report
- October 2023
- 85 Pages
India
From €3113EUR$3,450USD£2,705GBP
- Report
- October 2023
- 107 Pages
North America
From €3113EUR$3,450USD£2,705GBP
- Report
- May 2023
- 132 Pages
United States
From €3113EUR$3,450USD£2,705GBP
- Report
- April 2023
- 145 Pages
United States
From €3113EUR$3,450USD£2,705GBP
- Report
- December 2022
- 171 Pages
Africa, Middle East
From €3113EUR$3,450USD£2,705GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more